Multidrug resistance protein 3 loss promotes tumor formation by inducing senescence escape

C Wiel1,2,3,4, B Gras1,2,3,4, D Vindrieux1,2,3,4

  • 1Senescence Escape Mechanisms Laboratory, Tumoral Escape Department, Inserm U1052, Centre de Recherche en Cancérologie de Lyon, Lyon, France.

Oncogene
|June 16, 2015
PubMed

Insights

Loss of multidrug resistance protein 3 (MRP3 or ABCC3) allows cells to escape oncogenic-stress-induced senescence (OIS), promoting tumor formation. Reduced ABCC3 expression correlates with skin tumors and increased carcinogenesis sensitivity.

Area of Science:

  • Cellular biology
  • Cancer research
  • Molecular oncology

Background:

  • Oncogenic-stress-induced senescence (OIS) is a crucial tumor suppressive mechanism preventing uncontrolled cell proliferation.
  • Identifying genes that regulate escape from OIS is vital for understanding tumor development.
  • The multidrug resistance protein 3 (MRP3 or ABCC3) is known for its role in chemotherapy resistance.

Purpose of the Study:

  • To identify novel tumor suppressive pathways by screening for genes promoting escape from OIS.
  • To investigate the role of MRP3 (ABCC3) in OIS and its implications in cancer.

Main Methods:

  • Conducted a loss-of-function genetic screen in human epithelial cells to identify genes involved in OIS escape.
  • Analyzed ABCC3 expression in human skin tumors.
  • Utilized ABCC3-knockout mouse models to study RAS-induced skin carcinogenesis and OIS.

Main Results:

  • Loss of function of MRP3 (ABCC3) unexpectedly promotes escape from OIS in human epithelial cells.
  • ABCC3 expression is significantly reduced in human skin tumors.
  • ABCC3-knockout mice exhibit increased sensitivity to RAS-induced skin carcinogenesis, with diminished OIS.
  • The transporter activity of ABCC3 is implicated in its role in senescence.

Conclusions:

  • MRP3 (ABCC3) plays a complex dual role in cancer: loss of function promotes tumor initiation by enabling escape from OIS, while its transporter activity contributes to chemotherapy resistance.
  • Reduced ABCC3 expression is a potential marker for increased skin cancer risk.
  • Targeting ABCC3 function could offer new therapeutic strategies in oncology.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.6K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.3K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

2.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K